These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 16764960)

  • 1. Selective gene delivery for cancer therapy using cationic liposomes: in vivo proof of applicability.
    Dass CR; Choong PF
    J Control Release; 2006 Jun; 113(2):155-63. PubMed ID: 16764960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting of small molecule anticancer drugs to the tumour and its vasculature using cationic liposomes: lessons from gene therapy.
    Dass CR; Choong PF
    Cancer Cell Int; 2006 Jun; 6():17. PubMed ID: 16792817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cationic liposomes as non-viral carriers of gene medicines: resolved issues, open questions, and future promises.
    Karmali PP; Chaudhuri A
    Med Res Rev; 2007 Sep; 27(5):696-722. PubMed ID: 17022036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cationic liposomes for gene delivery.
    Simões S; Filipe A; Faneca H; Mano M; Penacho N; Düzgünes N; de Lima MP
    Expert Opin Drug Deliv; 2005 Mar; 2(2):237-54. PubMed ID: 16296751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oligonucleotide delivery to tumours using macromolecular carriers.
    Dass CR
    Biotechnol Appl Biochem; 2004 Oct; 40(Pt 2):113-22. PubMed ID: 15070400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor specific ultrasound enhanced gene transfer in vivo with novel liposomal bubbles.
    Suzuki R; Takizawa T; Negishi Y; Utoguchi N; Sawamura K; Tanaka K; Namai E; Oda Y; Matsumura Y; Maruyama K
    J Control Release; 2008 Jan; 125(2):137-44. PubMed ID: 18035442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro and in vivo evaluation of novel cationic liposomes utilized for cancer gene therapy.
    Serikawa T; Kikuchi A; Sugaya S; Suzuki N; Kikuchi H; Tanaka K
    J Control Release; 2006 Jul; 113(3):255-60. PubMed ID: 16793160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted gene therapy of LS174 T human colon carcinoma by anti-TAG-72 immunoliposomes.
    Kim KS; Lee YK; Kim JS; Koo KH; Hong HJ; Park YS
    Cancer Gene Ther; 2008 May; 15(5):331-40. PubMed ID: 18309354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene therapy progress and prospects: non-viral gene therapy by systemic delivery.
    Li SD; Huang L
    Gene Ther; 2006 Sep; 13(18):1313-9. PubMed ID: 16953249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of bacteria in anti-cancer therapies.
    Ryan RM; Green J; Lewis CE
    Bioessays; 2006 Jan; 28(1):84-94. PubMed ID: 16369949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted gene-delivery strategies for angiostatic cancer treatment.
    Brandwijk RJ; Griffioen AW; Thijssen VL
    Trends Mol Med; 2007 May; 13(5):200-9. PubMed ID: 17379575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting metastatic cancer from the inside: a new generation of targeted gene delivery vectors enables personalized cancer vaccination in situ.
    Gordon EM; Levy JP; Reed RA; Petchpud WN; Liu L; Wendler CB; Hall FL
    Int J Oncol; 2008 Oct; 33(4):665-75. PubMed ID: 18813779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The potential role of fucosylated cationic liposome/NFkappaB decoy complexes in the treatment of cytokine-related liver disease.
    Higuchi Y; Kawakami S; Yamashita F; Hashida M
    Biomaterials; 2007 Jan; 28(3):532-9. PubMed ID: 16982089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Gene therapy of critical ischemia of the legs. Improvement of genetic transfection efficiency of endothelial cells in vitro, using cationic liposomes and protamine sulfate].
    Costantini V; Allegrucci M; Paolucci MC; Ricci M; Stabile AM; Presilla MC; Nenci GG
    Minerva Cardioangiol; 1999 Dec; 47(12):662-3. PubMed ID: 10670251
    [No Abstract]   [Full Text] [Related]  

  • 15. Cationic liposomal lipids: from gene carriers to cell signaling.
    Lonez C; Vandenbranden M; Ruysschaert JM
    Prog Lipid Res; 2008 Sep; 47(5):340-7. PubMed ID: 18424270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clostridium neurotoxin fragments as potential targeting moieties for liposomal gene delivery to the CNS.
    Andreu A; Fairweather N; Miller AD
    Chembiochem; 2008 Jan; 9(2):219-31. PubMed ID: 18076008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of companion diagnostics in the development and use of mutation-targeted cancer therapies.
    Papadopoulos N; Kinzler KW; Vogelstein B
    Nat Biotechnol; 2006 Aug; 24(8):985-95. PubMed ID: 16900147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonviral delivery vehicles for use in short hairpin RNA-based cancer therapies.
    Vorhies JS; Nemunaitis J
    Expert Rev Anticancer Ther; 2007 Mar; 7(3):373-82. PubMed ID: 17338656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effective gene delivery with novel liposomal bubbles and ultrasonic destruction technology.
    Suzuki R; Takizawa T; Negishi Y; Utoguchi N; Maruyama K
    Int J Pharm; 2008 Apr; 354(1-2):49-55. PubMed ID: 18082343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery and development of folic-acid-based receptor targeting for imaging and therapy of cancer and inflammatory diseases.
    Low PS; Henne WA; Doorneweerd DD
    Acc Chem Res; 2008 Jan; 41(1):120-9. PubMed ID: 17655275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.